CN113186139B - 一株植物乳杆菌lr002及其应用 - Google Patents
一株植物乳杆菌lr002及其应用 Download PDFInfo
- Publication number
- CN113186139B CN113186139B CN202110687234.8A CN202110687234A CN113186139B CN 113186139 B CN113186139 B CN 113186139B CN 202110687234 A CN202110687234 A CN 202110687234A CN 113186139 B CN113186139 B CN 113186139B
- Authority
- CN
- China
- Prior art keywords
- lactobacillus plantarum
- strain
- resistance
- preparation
- application
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 240000006024 Lactobacillus plantarum Species 0.000 title claims abstract description 61
- 235000013965 Lactobacillus plantarum Nutrition 0.000 title claims abstract description 61
- 229940072205 lactobacillus plantarum Drugs 0.000 title claims abstract description 61
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 16
- 230000000968 intestinal effect Effects 0.000 claims abstract description 16
- 241000894006 Bacteria Species 0.000 claims abstract description 14
- 239000003833 bile salt Substances 0.000 claims abstract description 14
- 238000004321 preservation Methods 0.000 claims abstract description 7
- 238000002360 preparation method Methods 0.000 claims description 13
- 239000002253 acid Substances 0.000 claims description 11
- 230000003385 bacteriostatic effect Effects 0.000 claims description 7
- 241000589517 Pseudomonas aeruginosa Species 0.000 claims description 5
- 244000063299 Bacillus subtilis Species 0.000 claims description 4
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 4
- 241000588724 Escherichia coli Species 0.000 claims description 4
- 241000191967 Staphylococcus aureus Species 0.000 claims description 4
- 206010059866 Drug resistance Diseases 0.000 abstract description 15
- 210000004051 gastric juice Anatomy 0.000 abstract description 15
- 239000006041 probiotic Substances 0.000 abstract description 9
- 235000018291 probiotics Nutrition 0.000 abstract description 9
- 230000003115 biocidal effect Effects 0.000 abstract description 7
- 241001465754 Metazoa Species 0.000 abstract description 5
- 244000005700 microbiome Species 0.000 abstract description 3
- 238000000926 separation method Methods 0.000 abstract description 3
- 230000001580 bacterial effect Effects 0.000 description 24
- 239000001963 growth medium Substances 0.000 description 19
- 210000001035 gastrointestinal tract Anatomy 0.000 description 11
- 239000000725 suspension Substances 0.000 description 11
- 229940079593 drug Drugs 0.000 description 10
- 239000003814 drug Substances 0.000 description 10
- 239000007787 solid Substances 0.000 description 10
- 239000003242 anti bacterial agent Substances 0.000 description 8
- 229940088710 antibiotic agent Drugs 0.000 description 8
- 244000052616 bacterial pathogen Species 0.000 description 8
- 230000035945 sensitivity Effects 0.000 description 8
- 230000004083 survival effect Effects 0.000 description 8
- 230000000529 probiotic effect Effects 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 238000010586 diagram Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 108020004465 16S ribosomal RNA Proteins 0.000 description 3
- GSDSWSVVBLHKDQ-UHFFFAOYSA-N 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid Chemical compound FC1=CC(C(C(C(O)=O)=C2)=O)=C3N2C(C)COC3=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- 238000003794 Gram staining Methods 0.000 description 3
- 229930193140 Neomycin Natural products 0.000 description 3
- 229930182555 Penicillin Natural products 0.000 description 3
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 3
- 239000004098 Tetracycline Substances 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 229940093761 bile salts Drugs 0.000 description 3
- 229960004261 cefotaxime Drugs 0.000 description 3
- AZZMGZXNTDTSME-JUZDKLSSSA-M cefotaxime sodium Chemical compound [Na+].N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C([O-])=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 AZZMGZXNTDTSME-JUZDKLSSSA-M 0.000 description 3
- 229960001231 choline Drugs 0.000 description 3
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000015784 hyperosmotic salinity response Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 238000009630 liquid culture Methods 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- FXWHFKOXMBTCMP-WMEDONTMSA-N milbemycin Natural products COC1C2OCC3=C/C=C/C(C)CC(=CCC4CC(CC5(O4)OC(C)C(C)C(OC(=O)C(C)CC(C)C)C5O)OC(=O)C(C=C1C)C23O)C FXWHFKOXMBTCMP-WMEDONTMSA-N 0.000 description 3
- 229960004927 neomycin Drugs 0.000 description 3
- 229960001699 ofloxacin Drugs 0.000 description 3
- 229940049954 penicillin Drugs 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 229960002180 tetracycline Drugs 0.000 description 3
- 229930101283 tetracycline Natural products 0.000 description 3
- 235000019364 tetracycline Nutrition 0.000 description 3
- 150000003522 tetracyclines Chemical class 0.000 description 3
- 238000012935 Averaging Methods 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000005034 decoration Methods 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 239000012982 microporous membrane Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- SGKRLCUYIXIAHR-AKNGSSGZSA-N (4s,4ar,5s,5ar,6r,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1=CC=C2[C@H](C)[C@@H]([C@H](O)[C@@H]3[C@](C(O)=C(C(N)=O)C(=O)[C@H]3N(C)C)(O)C3=O)C3=C(O)C2=C1O SGKRLCUYIXIAHR-AKNGSSGZSA-N 0.000 description 1
- KEQXNNJHMWSZHK-UHFFFAOYSA-L 1,3,2,4$l^{2}-dioxathiaplumbetane 2,2-dioxide Chemical compound [Pb+2].[O-]S([O-])(=O)=O KEQXNNJHMWSZHK-UHFFFAOYSA-L 0.000 description 1
- 240000006162 Chenopodium quinoa Species 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 229960004821 amikacin Drugs 0.000 description 1
- LKCWBDHBTVXHDL-RMDFUYIESA-N amikacin Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O1)O)NC(=O)[C@@H](O)CCN)[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1O LKCWBDHBTVXHDL-RMDFUYIESA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 229940040526 anhydrous sodium acetate Drugs 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 229960004682 cefoperazone Drugs 0.000 description 1
- GCFBRXLSHGKWDP-XCGNWRKASA-N cefoperazone Chemical compound O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC(O)=CC=1)C(=O)N[C@@H]1C(=O)N2C(C(O)=O)=C(CSC=3N(N=NN=3)C)CS[C@@H]21 GCFBRXLSHGKWDP-XCGNWRKASA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940099352 cholate Drugs 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- -1 diamine citrate Chemical class 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229960003722 doxycycline Drugs 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- XJRPTMORGOIMMI-UHFFFAOYSA-N ethyl 2-amino-4-(trifluoromethyl)-1,3-thiazole-5-carboxylate Chemical compound CCOC(=O)C=1SC(N)=NC=1C(F)(F)F XJRPTMORGOIMMI-UHFFFAOYSA-N 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Communicable Diseases (AREA)
- Food Science & Technology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110687234.8A CN113186139B (zh) | 2021-06-21 | 2021-06-21 | 一株植物乳杆菌lr002及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110687234.8A CN113186139B (zh) | 2021-06-21 | 2021-06-21 | 一株植物乳杆菌lr002及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113186139A CN113186139A (zh) | 2021-07-30 |
CN113186139B true CN113186139B (zh) | 2022-06-07 |
Family
ID=76976593
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110687234.8A Active CN113186139B (zh) | 2021-06-21 | 2021-06-21 | 一株植物乳杆菌lr002及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113186139B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114657106B (zh) * | 2022-04-21 | 2023-11-21 | 青岛蔚蓝生物股份有限公司 | 一株植物乳植杆菌及其在防治痤疮中的应用 |
CN115181695B (zh) * | 2022-06-27 | 2023-08-29 | 广东粤港澳大湾区国家纳米科技创新研究院 | 一种植物乳杆菌5b4m2及其应用 |
CN116970513B (zh) * | 2023-05-12 | 2024-04-30 | 山东省农业科学院 | 一株植物乳植杆菌sq6及其应用 |
CN118240712B (zh) * | 2024-05-23 | 2024-08-30 | 内蒙古蒙牛乳业(集团)股份有限公司 | 促生长益生菌和应用 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102586155A (zh) * | 2012-03-07 | 2012-07-18 | 江南大学 | 一种植物乳杆菌n13及其用途 |
CN104818230A (zh) * | 2015-05-05 | 2015-08-05 | 广西科技大学 | 一株具有降解胆固醇功能的植物乳杆菌l01及其应用 |
CN109022313A (zh) * | 2018-08-02 | 2018-12-18 | 中国农业科学院兰州兽医研究所 | 一株植物乳杆菌 |
CN110747140A (zh) * | 2018-10-18 | 2020-02-04 | 江南大学 | 一种具有硒吸附能力的植物乳杆菌及其用途 |
CN113061543A (zh) * | 2020-01-02 | 2021-07-02 | 北京科丽科技有限公司 | 一种植物乳杆菌及其用途 |
CN113215018A (zh) * | 2021-02-04 | 2021-08-06 | 郑州大学 | 一株植物乳杆菌植物亚种及其在豆粕和北艾混合发酵中的应用 |
CN113416673A (zh) * | 2021-06-21 | 2021-09-21 | 西北民族大学 | 一种用于棉粕脱毒的复合菌剂及其制备方法和应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016205394A1 (en) * | 2015-06-15 | 2016-12-22 | Amnat Global Llc | Multistrain probiotic blends for treatment of gastrointestinal conditions and improving or maintaining gastrointestinal health |
CN105132318B (zh) * | 2015-09-01 | 2018-07-06 | 扬州大学 | 植物乳杆菌Grx16及其应用 |
WO2019174003A1 (zh) * | 2018-03-15 | 2019-09-19 | 江南大学 | 植物乳杆菌ccfm1019、其发酵食品及其在制备药物中的应用 |
CN111040960B (zh) * | 2019-11-19 | 2022-02-01 | 西南大学 | 植物乳杆菌lp33及其在制备用于促进铅排泄的产品中的应用 |
-
2021
- 2021-06-21 CN CN202110687234.8A patent/CN113186139B/zh active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102586155A (zh) * | 2012-03-07 | 2012-07-18 | 江南大学 | 一种植物乳杆菌n13及其用途 |
CN104818230A (zh) * | 2015-05-05 | 2015-08-05 | 广西科技大学 | 一株具有降解胆固醇功能的植物乳杆菌l01及其应用 |
CN109022313A (zh) * | 2018-08-02 | 2018-12-18 | 中国农业科学院兰州兽医研究所 | 一株植物乳杆菌 |
CN110747140A (zh) * | 2018-10-18 | 2020-02-04 | 江南大学 | 一种具有硒吸附能力的植物乳杆菌及其用途 |
CN113061543A (zh) * | 2020-01-02 | 2021-07-02 | 北京科丽科技有限公司 | 一种植物乳杆菌及其用途 |
CN113215018A (zh) * | 2021-02-04 | 2021-08-06 | 郑州大学 | 一株植物乳杆菌植物亚种及其在豆粕和北艾混合发酵中的应用 |
CN113416673A (zh) * | 2021-06-21 | 2021-09-21 | 西北民族大学 | 一种用于棉粕脱毒的复合菌剂及其制备方法和应用 |
Non-Patent Citations (8)
Title |
---|
一株鱼源植物乳杆菌的部分生物学特性研究;曲磊等;《黑龙江畜牧兽医》;20180310(第05期);第188-191页 * |
产多糖植物乳杆菌的耐酸耐胆盐能力;赵小茜等;《乳液科学与技术》;20160803;第39卷(第3期);第1-3页 * |
棉酚脱毒菌的筛选鉴定及其棉籽粕发酵试验研究;舒文秀;《中国优秀硕士论文电子期刊农业科技辑》;20210815(第8期);D050-53 * |
植物乳杆菌对仔猪肠道健康的影响;崔艳红等;《饲料工业》;20180425(第08期);第36-40页 * |
母乳源植物乳杆菌WLP04的益生评价及其对小鼠免疫和肠道菌群的影响;江美玲;《万方》;20170428;第1-71页 * |
猪源益生乳酸菌的筛选及其菌剂制备技术研究;熊涛;《万方》;20180514;第1-73页 * |
自然发酵泡菜汁中植物乳杆菌的分离鉴定与体外益生特性研究;侯颖等;《动物营养学报》;20171122(第10期);第190-198页 * |
降胆固醇乳酸菌的筛选和分析比较;彭灿等;《中国微生态学杂志》;20170315(第03期);第7-13页 * |
Also Published As
Publication number | Publication date |
---|---|
CN113186139A (zh) | 2021-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113186139B (zh) | 一株植物乳杆菌lr002及其应用 | |
CN111534446B (zh) | 罗伊氏乳杆菌及其应用 | |
CN109055268B (zh) | 一种复合微生态制剂及其在蜜蜂养殖过程中的应用 | |
CN111100821B (zh) | 一种链球菌及其应用 | |
CN109182165B (zh) | 一株瑞士乳杆菌及其在蜜蜂养殖过程中的应用 | |
CN110628663B (zh) | 一株鼠李糖乳杆菌及其高密度培养方法和应用 | |
Ahmed | Prevalence of Proteus spp. in some hospitals in Baghdad City | |
CN112812999B (zh) | 一株对阴沟肠杆菌具有抑制作用的植物乳杆菌slb01及其衍生产品和应用 | |
CN114107133A (zh) | 一种抗结直肠肿瘤的屎肠球菌及其应用 | |
CN111019858B (zh) | 一种抑制细菌生物膜形成的饲用地衣芽孢杆菌及其应用 | |
CN112063566B (zh) | 一株屎肠球菌及其应用 | |
CN117327626A (zh) | 一种植物乳杆菌ts1及其培养方法与应用 | |
CN116478873B (zh) | 一种民猪肠道中可抑制多种有害菌生长的贝莱斯芽孢杆菌 | |
CN117660253A (zh) | 一种鼠李糖乳酪杆菌fmbl l23004 cnn、酸奶发酵剂、酸奶及其应用 | |
CN117801981A (zh) | 一株促进肉鸡生长的益生乳酸菌的筛选及应用 | |
CN114717150B (zh) | 一种植物乳杆菌crs33及其应用 | |
CN115651860B (zh) | 凝结芽孢杆菌bc-hyc株及其应用 | |
CN113604387B (zh) | 一株耐盐、耐高温罗伊氏乳杆菌及其在畜禽水产养殖中防治病原菌的应用 | |
CN114874952A (zh) | 干酪乳杆菌hjd及其应用 | |
CN111154677B (zh) | 嗜酸乳杆菌及其应用 | |
CN113234641B (zh) | 一株耐低温、产蛋白酶的芽孢杆菌s77及其应用 | |
CN114381387A (zh) | 一株唾液乳杆菌s32及其应用 | |
KR20140146503A (ko) | 신규미생물 바실러스 서브틸러스 sj-30 및 이를 포함하고 있는 어류용 사료첨가제 | |
RU2451085C2 (ru) | Способ определения антибактериальной активности аэробных споровых микроорганизмов bacillus subtilis | |
CN111607542A (zh) | 一种微生态制剂及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231017 Address after: 731100 Sanmatai, Taiji Town, Yongjing County, Linxia Hui Autonomous Prefecture, Gansu Province Patentee after: YONGJING RUILIN TECHNOLOGY BREEDING CO.,LTD. Address before: 730030, 1 northwest village, Chengguan District, Gansu, Lanzhou Patentee before: NORTHWEST University FOR NATIONALITIES |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231025 Address after: 730000 No. 106 Pingliang Road, Chengguan District, Lanzhou City, Gansu Province Patentee after: Gansu Provincial Agricultural Ecology and Resource Protection Technology Promotion Station Address before: 731100 Sanmatai, Taiji Town, Yongjing County, Linxia Hui Autonomous Prefecture, Gansu Province Patentee before: YONGJING RUILIN TECHNOLOGY BREEDING CO.,LTD. |